Discover
PRCT
PROCEPT BioRobotics Corporation
23.47
2 x 17.26
2 x 29.79
bid
ask
+
0.89
3.94%
2 @ 04:06 AM
23.35 -0.12 (0.51%)
| Ytd | -25.40% | |
| 1y | -58.51% |
22.89
day range
24.20
19.35
52 week range
62.17
| Open | 22.93 | Prev Close | 22.58 | Low | 22.89 | High | 24.20 | Mkt Cap | 1.34B |
| Vol | 1.31M | Avg Vol | 1.54M | EPS | -1.83 | P/E | N/A | Forward P/E | -25.95 |
| Beta | 0.85 | Short Ratio | 5.45 | Inst. Own | 102.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-29 | 50-d Avg | 25.18 | 200-d Avg | 29.34 | 1yr Est | 30.20 |
| Income Statement | |||
| Total Revenue | 83.13M | ||
| Revenues (USD) | 83.13M | ||
| Cost of Revenue | 29.19M | ||
| Gross Profit | 53.95M | ||
| Operating Expenses | 86.55M | ||
| Research and Development Expense | 21.47M | ||
| Selling, General and Administrative Expense | 65.09M | ||
| Operating Income | -32.61M | ||
| Interest Expense | 818.00K | ||
| Income Tax Expense | -43.00K | ||
| Net Income | -31.64M | ||
| Net Income Common Stock | -31.64M | ||
| Net Income Common Stock (USD) | -31.64M | ||
| Consolidated Income | -31.64M | ||
| Earnings per Basic Share | -0.56 | ||
| Earnings per Basic Share (USD) | -0.56 | ||
| Earnings per Diluted Share | -0.56 | ||
| Earning Before Interest & Taxes (EBIT) | -30.86M | ||
| Earning Before Interest & Taxes (USD) | -30.86M | ||
| Weighted Average Shares | 56.51M | ||
| Weighted Average Shares Diluted | 56.51M | ||
| Balance Sheet | |||
| Cash and Equivalents | 245.64M | ||
| Cash and Equivalents (USD) | 245.64M | ||
| Investments | 3.04M | ||
| Investments Non-Current | 3.04M | ||
| Trade and Non-Trade Receivables | 96.39M | ||
| Current Assets | 428.03M | ||
| Property, Plant & Equipment Net | 48.90M | ||
| Total Assets | 487.06M | ||
| Debt Current | 2.36M | ||
| Total Debt | 78.00M | ||
| Current Liabilities | 63.64M | ||
| Debt Non-Current | 75.64M | ||
| Total Liabilities | 139.40M | ||
| Accumulated Retained Earnings (Deficit) | -673.19M | ||
| Accumulated Other Comprehensive Income | -19.00K | ||
| Shareholders Equity | 347.67M | ||
| Shareholders Equity (USD) | 347.67M | ||
| Assets Non-Current | 59.03M | ||
| Total Debt (USD) | 78.00M | ||
| Deferred Revenue | 13.70M | ||
| Goodwill and Intangible Assets | 640.00K | ||
| Inventory | 77.54M | ||
| Liabilities Non-Current | 75.76M | ||
| Trade and Non-Trade Payables | 18.85M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.58M | ||
| Net Cash Flow from Financing | 222.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -40.86M | ||
| Capital Expenditure | -2.91M | ||
| Issuance (Purchase) of Equity Shares | 222.00K | ||
| Net Cash Flow from Investing | -2.91M | ||
| Net Cash Flow from Operations | -38.13M | ||
| Effect of Exchange Rate Changes on Cash | -42.00K | ||
| Share Based Compensation | 13.07M | ||